Since we found that PHLDA2 inhibits AKT activation through interfering with AKT translocation to the plasma membrane and further showed that this is mediated by direct competition with AKT to bind membrane lipids, we next examined whether PHLDA2 acts as a functional tumor suppressor in lung cancer. Here, PHLDA2 is linked to neoplasm.